Genomma Lab Internacional SAB de CVBMV: LAB/B

LAB/B: Q3 delivered robust sales, margin, and cash flow growth, with strong outlook and disciplined capital use

· Issued by Genomma Lab Internacional SAB de CV

Q3 2024 saw double-digit sales and profit growth, margin expansion, and record cash flow, driven by strong performance in Mexico, the US, and Argentina. Productivity initiatives, brand acquisitions, and disciplined capital allocation support continued growth and margin improvement.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Genomma Lab Internacional SAB de CV on 6ix

Earlier from Genomma Lab Internacional SAB de CV

Later from Genomma Lab Internacional SAB de CV

All Genomma Lab Internacional SAB de CV news releases